Checkpoint therapeutic target database (CKTTD): the first comprehensive database for checkpoint targets and their modulators in cancer immunotherapy
Yixiao Zhang,Yuan Yao,Peng Chen,Yu Liu,Hao Zhang,He Liu,Yu LiuĀ,Hong Xu,Xibao Tian,Zichu Wang,Peng Chu,Dongyu Zhao,Hongxu Liu,Chenlei Zhang,Shuyuan Chen,Yuhong Zhao,Caigang Liu,Yongliang Yang
DOI: https://doi.org/10.1136/jitc-2020-001247
IF: 12.469
2020-10-01
Journal for ImmunoTherapy of Cancer
Abstract:Background Checkpoint targets play a key role in tumor-mediated immune escape and therefore are critical for cancer immunotherapy. Unfortunately, there is a lack of bioinformatics resource that compile all the checkpoint targets for translational research and drug discovery in immuno-oncology. Methods To this end, we developed checkpoint therapeutic target database (CKTTD), the first comprehensive database for immune checkpoint targets (proteins, miRNAs and LncRNAs) and their modulators. A scoring system was adopted to filter more relevant targets with high confidence. In addition, a few biological databases such as Oncomine, Drugbank, miRBase and Lnc2Cancer database were integrated into CKTTD to provide an in-depth information. Moreover, we computed and provided ligand-binding site information for all the targets which may support bench scientists for drug discovery efforts. Results In total, CKTTD compiles 105 checkpoint protein targets, 53 modulators (small-molecules and antibody), 30 miRNAs and 18 LncRNAs in cancer immunotherapy with validated experimental evidences curated from 10 649 literatures via an enhanced text-mining system. Conclusions In conclusion, the CKTTD may serve as a useful platform for the research of cancer immunotherapy and drug discovery. The CKTTD database is freely available to public at http://www.ckttdb.org/ .
oncology,immunology